These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30538263)

  • 1. TNFα-stimulated protein 6 (TSG-6) reduces lung inflammation in an experimental model of bronchopulmonary dysplasia.
    Bryan C; Sammour I; Guerra K; Sharma M; Dapaah-Siakwan F; Huang J; Zambrano R; Benny M; Wu S; Young K
    Pediatr Res; 2019 Feb; 85(3):390-397. PubMed ID: 30538263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia.
    Guerra K; Bryan C; Dapaah-Siakwan F; Sammour I; Drummond S; Zambrano R; Chen P; Huang J; Sharma M; Shrager S; Benny M; Wu S; Young KC
    Respir Res; 2019 Nov; 20(1):255. PubMed ID: 31718614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
    Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
    Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
    Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats.
    Drummond S; Ramachandran S; Torres E; Huang J; Hehre D; Suguihara C; Young KC
    Neonatology; 2015; 107(4):304-11. PubMed ID: 25825119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
    Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Leukadherin-1 in the Prevention of Hyperoxia-Induced Lung Injury in Neonatal Rats.
    Jagarapu J; Kelchtermans J; Rong M; Chen S; Hehre D; Hummler S; Faridi MH; Gupta V; Wu S
    Am J Respir Cell Mol Biol; 2015 Dec; 53(6):793-801. PubMed ID: 25909334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.
    Reiter J; Drummond S; Sammour I; Huang J; Florea V; Dornas P; Hare JM; Rodrigues CO; Young KC
    Respir Res; 2017 Jul; 18(1):137. PubMed ID: 28701189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia.
    Jiménez J; Lesage F; Richter J; Nagatomo T; Salaets T; Zia S; Mori Da Cunha MG; Vanoirbeek J; Deprest JA; Toelen J
    Neonatology; 2018; 113(3):275-285. PubMed ID: 29393249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
    Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
    Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tie-2 Cre-Mediated Deficiency of Extracellular Signal-Regulated Kinase 2 Potentiates Experimental Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonatal Mice.
    Menon RT; Shrestha AK; Barrios R; Reynolds C; Shivanna B
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose Stem Cells Derived Exosomes Alleviate Bronchopulmonary Dysplasia and Regulate Autophagy in Neonatal Rats.
    Sun Y; Chen C; Liu Y; Sheng A; Wang S; Zhang X; Wang D; Wang Q; Lu C; Lin Z
    Curr Stem Cell Res Ther; 2024; 19(6):919-932. PubMed ID: 37817518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
    Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genipin attenuates hyperoxia-induced lung injury and pulmonary hypertension via targeting glycogen synthase kinase-3 β in neonatal rats.
    Li J; Shi J; Li P; Guo X; Wang T; Liu A
    Nutrition; 2019 Jan; 57():237-244. PubMed ID: 30196116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
    Sharma M; Bellio MA; Benny M; Kulandavelu S; Chen P; Janjindamai C; Han C; Chang L; Sterling S; Williams K; Damianos A; Batlahally S; Kelly K; Aguilar-Caballero D; Zambrano R; Chen S; Huang J; Wu S; Hare JM; Schmidt A; Khan A; Young K
    Stem Cells Transl Med; 2022 Aug; 11(8):828-840. PubMed ID: 35758326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
    Qu S; Shan L; Chen X; Zhang Z; Wu Y; Chen Y; Zhuo F; Wang Y; Dong H
    BMC Pulm Med; 2023 Jun; 23(1):209. PubMed ID: 37322452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin improves alveolarization and vascular development in hyperoxia-induced bronchopulmonary dysplasia by inhibiting neutrophil extracellular traps.
    Sun Y; Chen C; Zhang X; Wang S; Zhu R; Zhou A; Chen S; Feng J
    Biochem Biophys Res Commun; 2020 Jan; 522(1):33-39. PubMed ID: 31735330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.
    Gong J; Feng Z; Peterson AL; Carr JF; Vang A; Braza J; Choudhary G; Dennery PA; Yao H
    J Pathol; 2020 Dec; 252(4):411-422. PubMed ID: 32815166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth.
    Donda K; Zambrano R; Moon Y; Percival J; Vaidya R; Dapaah-Siakwan F; Luo S; Duncan MR; Bao Y; Wang L; Qin L; Benny M; Young K; Wu S
    PLoS One; 2018; 13(7):e0199927. PubMed ID: 29990355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.